bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.09.27.678967

Multiscale predictive modeling robustly improves the accuracy of pseudo-prospective seizure forecasting in drug-resistant epilepsy

Abstract

Extensive research over the past two decades has focused on identifying a preictal period in scalp as well as intracranial EEG (iEEG). This has led to a plethora of seizure prediction and forecasting algorithms which have reached only moderate success on curated and pre-segmented EEG datasets (accuracy/AUC {gtrsim} 0.8). Furthermore, when tested on their ability to pseudo-prospectively predict seizures from continuous EEG recordings, all existing algorithms suffer from low sensitivity (large false negatives), high time in warning (large false positives), or both. In this study we provide pilot evidence that predictive modeling of the dynamics of iEEG features (biomarkers), seizure risk, or both at the scale of tens of minutes can significantly improve the pseudo-prospective accuracy of almost any state-of-the-art seizure forecasting model. In contrast to the bulk of prior research that has focused on designing better features and classifiers, we start from off-the-shelf features and classifiers and shift the focus to learning how iEEG features (classifier input) and seizure risk (classifier output) evolve over time. Using iEEG from n = 5 patients undergoing presurgical evaluation at the Hospital of the University of Pennsylvania and six state-of-the-art baseline models, we first demonstrate that a wide array of iEEG features are highly predictable over time, with over 99% and 35% of studied features, respectively, having R2 > 0 for 10-second- and 10-minute-ahead prediction (mean R2 of 0.85 and 0.2). Furthermore, in almost all patients and baseline models, we observe a strong correlation between feature predictability (with some features remaining predictable up to 30 minutes) and classification-based feature importance. As a result, we subsequently demonstrate that adding an autoregressive model that predicts iEEG features on 12 {+/-} 4 minutes into the future is almost universally beneficial, with a mean improvement of 28% in terms of area under pseudo-prospective sensitivity-time in warning curve (PP-AUC). Addition of the second autoregressive predictive model at the level of seizure risk further improved accuracy, with a total mean improvement of 51% in PP-AUC. Our results provide pioneering evidence for the long-term predictability of seizure-relevant iEEG features and the vast utility of time series predictive modeling for improving seizure forecasting using continuous intracranial EEG.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Nozari, E., Acharya, G., Davis, K. A., Conrad, E.. 2025-09-28. Multiscale predictive modeling robustly improves the accuracy of pseudo-prospective seizure forecasting in drug-resistant epilepsy. https://doi.org/10.1101/2025.09.27.678967

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗